Article citationsMore>>

Talamonti, M., Botti, E., Galluzzo, M., Teoli, M., Spallone, G., Bavetta, M., et al. (2013) Pharmacogenetics of Psoriasis: HLA-Cw6 But Not LCE3B/3C Deletion nor TNFAIP3 Polymorphism Predisposes to Clinical Response to Interleukin 12/23 Blocker Ustekinumab. British Journal of Dermatology, 169, 458-463.
https://doi.org/10.1111/bjd.12331

has been cited by the following article:

SCIRP Newsletter
Copyright © 2006-2026 Scientific Research Publishing Inc. All Rights Reserved.
Top